While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Chemours (CC) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.31 per share a year ago.
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Truist Securities analyst Peter Osterland initiated coverage on several chemicals stocks ahead of earnings release.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
The Chemours Company CC recently announced that the PCC Group intends to build and operate a chlor-alkali facility on the grounds of Chemours' titanium dioxide (TiO2) plant in DeLisle, MS. Chemours and PCC have signed a chlorine supply agreement subject to certain customary conditions.
Chemours (CC) reported earnings 30 days ago. What's next for the stock?
Chemours Company has underperformed the Russell 2000 and other material stocks in 2024, with negative returns of 36% on a YTD basis. Even though the current quarter is unlikely to be the greatest on account of seasonal issues, we are choosing to be cautiously optimistic on CC now. CC's most profitable division by far -Thermal & Specialized Solutions, is driving topline growth again, as regulatory tailwinds abet the Opteon portfolio.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
CC sees record Q3 sales in the Thermal & Specialized Solutions division, driven by the growth in Opteon refrigerants.
The Chemours Company (NYSE:CC ) Q3 2024 Earnings Call Transcript November 4, 2024 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - CFO Conference Call Participants Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Mike Leithead - Barclays Vincent Andrews - Morgan Stanley Laurence Alexander - Jefferies John Roberts - Mizuho Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Operator Good morning. My name is Daniel and I will be your conference operator today.
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.